The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Exparel (bupivacaine liposome injectable suspension) to include both single-dose sciatic nerve ...
Patients who underwent lower limb orthopedic surgery and received a single-shot femoral nerve block had an increased risk for falls during the early postoperative period. Recipients of a single-shot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results